Literature DB >> 31828742

The myopic shift associated with hyperbaric oxygen administration is reduced when using a mask delivery system compared to a hood - a randomised controlled trial.

Michael H Bennett1,2,3, Cheng Fb Hui1,2, Hooi G See4, Kwan L Au-Yeung5, Christopher Tan6, Stephanie Watson1,7.   

Abstract

INTRODUCTION: A temporary myopic shift is a well-recognized complication of hyperbaric oxygen treatment (HBOT). Oxidation of proteins in the crystalline lens is the likely cause. Direct exposure of the eye to hyperbaric oxygen may exacerbate the effect. Our aim was to measure the magnitude of the myopic shift over a course of HBOT when using two different methods of oxygen delivery.
METHODS: We conducted a randomised trial of oxygen delivery via hood versus oronasal mask during a course of 20 and 30 HBOT sessions. Subjective refraction was performed at baseline and after 20 and 30 sessions. We repeated these measurements at four and 12 weeks after completion of the course in those available for assessment.
RESULTS: We enrolled 120 patients (mean age 57.6 (SD 11.2) years; 81% male). The myopic shift was significantly greater after both 20 and 30 sessions in those patients using the hood. At 20 treatments: refractory change was -0.92 D with hood versus -0.52 D with mask, difference 0.40 D (95% CI 0.22 to 0.57, P < 0.0001); at 30 treatments: -1.25 D with hood versus -0.63 with mask, difference 0.62 D (95% CI 0.39 to 0.84, P < 0.0001). Recovery was slower and less complete in the hood group at both four and 12 weeks.
CONCLUSIONS: Myopic shift is common following HBOT and more pronounced using a hood system than an oronasal mask. Recovery may be slower and less complete using a hood. Our data support the use of an oronasal mask in an air environment when possible. Copyright: This article is the copyright of the authors who grant Diving and Hyperbaric Medicine a non-exclusive licence to publish the article in electronic and other forms.

Entities:  

Keywords:  Hyperbaric oxygen; Myopia; Ophthalmology; Side effects; Vision

Mesh:

Substances:

Year:  2019        PMID: 31828742      PMCID: PMC7039782          DOI: 10.28920/dhm49.4.245-252

Source DB:  PubMed          Journal:  Diving Hyperb Med        ISSN: 1833-3516            Impact factor:   0.887


  21 in total

1.  Myopic Shift during Hyperbaric Oxygenation Attributed to Lens Index Changes.

Authors:  Knut Evanger; Barbara K Pierscionek; Guro Vaagbø; Einar Thorsen; Olav H Haugen
Journal:  Optom Vis Sci       Date:  2015-11       Impact factor: 1.973

2.  Efficient oxygen mask for patients undergoing hyperbaric oxygen therapy.

Authors:  P J Sheffield; R L Stork; T R Morgan
Journal:  Aviat Space Environ Med       Date:  1977-02

3.  Tenth European Consensus Conference on Hyperbaric Medicine: recommendations for accepted and non-accepted clinical indications and practice of hyperbaric oxygen treatment.

Authors:  Daniel Mathieu; Alessandro Marroni; Jacek Kot
Journal:  Diving Hyperb Med       Date:  2017-03       Impact factor: 0.887

4.  Oxidation-induced changes in human lens epithelial cells. 1. Phospholipids.

Authors:  Li Huang; Rosendo Estrada; Marta C Yappert; Douglas Borchman
Journal:  Free Radic Biol Med       Date:  2006-08-04       Impact factor: 7.376

5.  Hyperbaric oxygen in vivo accelerates the loss of cytoskeletal proteins and MIP26 in guinea pig lens nucleus.

Authors:  V A Padgaonkar; L R Lin; V R Leverenz; A Rinke; V N Reddy; F J Giblin
Journal:  Exp Eye Res       Date:  1999-04       Impact factor: 3.467

6.  Refractive change during hyperbaric oxygen therapy. A clinical trial including ultrasound oculometry.

Authors:  Hans C Fledelius; Erik C Jansen; Jens Thorn
Journal:  Acta Ophthalmol Scand       Date:  2002-04

7.  Nuclear cataract and myopia during hyperbaric oxygen therapy.

Authors:  B M Palmquist; B Philipson; P O Barr
Journal:  Br J Ophthalmol       Date:  1984-02       Impact factor: 4.638

8.  Oxygen therapy and intraocular oxygenation.

Authors:  L M Jampol
Journal:  Trans Am Ophthalmol Soc       Date:  1987

9.  Nuclear light scattering, disulfide formation and membrane damage in lenses of older guinea pigs treated with hyperbaric oxygen.

Authors:  F J Giblin; V A Padgaonkar; V R Leverenz; L R Lin; M F Lou; N J Unakar; L Dang; J E Dickerson; V N Reddy
Journal:  Exp Eye Res       Date:  1995-03       Impact factor: 3.467

10.  Ocular refractive changes in patients receiving hyperbaric oxygen administered by oronasal mask or hood.

Authors:  Knut Evanger; Olav H Haugen; Agot Irgens; Leif Aanderud; Einar Thorsen
Journal:  Acta Ophthalmol Scand       Date:  2004-08
View more
  1 in total

1.  Effect of antiplatelet and/or anticoagulation medication on the risk of tympanic barotrauma in hyperbaric oxygen treatment patients, and development of a predictive model.

Authors:  Adam E Howard; Peter Buzzacott; Ian C Gawthrope; Neil D Banham
Journal:  Diving Hyperb Med       Date:  2020-12-20       Impact factor: 0.887

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.